Despite Controversy, Human Studies of CRISPR Move Forward in the U.S.

Aug 14, 2019

Despite Controversy, Human Studies of CRISPR Move Forward in the U.S.

Posted by Genevieve O’Hagan in category: biotech/medical

The technology that produced a global scandal in China last year has entered into clinical trials to treat sickle cell anemia and an eye disease.

Leave a reply

GETAS THREAT LEVEL: GUARDED
TOP DONOR: BRIAN CARTMELL
#2 DONOR: DONALD MACLEAN
#3 DONOR: JEFF BONE/TOPSIGHT FUND
#4 DONOR: PEG KAY

LF FUND: $594,573.68
BITCOIN ENDOWMENT: $6,975,623.40
A-PRIZE: $30,013.00
NANOSHIELD: $17,018.00
X-RISKS NETWORK: $3,108.00
AISHIELD: $4,112.00

LIFEBOAT NEWS: 3,014 SUBSCRIBERS
GETAS ALERTS: 435 SUBSCRIBERS
BLOG: 48,380 POSTS
BOARDS: 2,842 MEMBERS
REPORTS: 55
PROGRAMS: 25
FORUMS: 13
QUOTES: 136

FACEBOOK: 8,341 MEMBERS
LINKEDIN: 1,983 MEMBERS
TWITTER FEED: 33,526 MEMBERS
FIGHT AIDS: 3 MEMBERS
[email protected]: 15 MEMBERS
[email protected]: 44 MEMBERS
A-PRIZE: 55 MEMBERS
NANOSHIELD: 69 MEMBERS
AISHIELD: 25 MEMBERS

DONORS: 3,923
LF-500: 13 MEMBERS
PATRON: 1 MEMBER
FIRST CLASS: 1 MEMBER
EXECUTIVE: 12 MEMBERS
ECONOMY: 23 MEMBERS
A-500: 1 MEMBER

© 2002–2020 Lifeboat Foundation